Furthermore, XPO1 has been identified to be involved in the regulation of several neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal dementia (Archbold et al., 2018; Ederle et al., 2018; Steyaert et al., 2018). Here, XPO1 is linked to neurodegenerative disease.